For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
Trump administration decision highlights disastrous Part D redesign
The Trump administration recently announced the end of a demonstration project that was pulled together by the Biden administration as the Inflation Reduction…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Blog
State Directed Payments redistribute money across states and supercharged growth
Differences in states’ use of SDPs cause an interstate redistribution of taxes as well. Because states are setting different levels of SDPs, spending varies…
Search Posts
Op-Eds
Waiting to Inhale: ‘Thank You for Smoking’
<?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> Few industries are more demonized than Big Tobacco. From…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. TECHNOLOGY Secretary of Commerce Carlos Gutierrez announces the creation of a new center for…
Op-Eds
Politics Nixed In Cancer Stick Flick
When Christopher Buckley’s novel Thank You for Smoking came out in 1994 it was a surprising satire of the vilification of the tobacco…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. HEALTH The United Nations marks the importance of clean drinking water in the developing world with…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. ENERGY Ethanol producers could face problems during the summer driving season when demand is expected to…
Op-Eds
New Drug Demagoguery
“New Drugs Hit the Market, but Promised Trials Go Undone” and “FDA: Drug Companies Drop Ball on Studies,” the headlines blared.